昊海生科: 上海昊海生物科技股份有限公司关于注销已回购H股股份的公告

Group 1 - The company has completed the repurchase and cancellation of H shares, resulting in a reduction of total share capital from 233,193,695 shares to 232,581,095 shares [1][2] - The repurchase was authorized during the 2023 annual general meeting and subsequent shareholder meetings, allowing the board to proceed with the cancellation of H shares [1] - Following the cancellation, the structure of the share capital has changed, with A shares increasing from 83.2149% to 83.4341% of total shares, while H shares decreased from 16.7851% to 16.5659% [2]